LINC-ROR and neoplasm: We then detected the expression of ROR in stable cell clones selected with puromycin and found that ROR expression was knocked down in two shROR-expressing AGS (Fig. 1c, lanes 2 and 4) and HT29 tumor cells (Fig. 1d, lanes 2 and 4).